Trial Profile
Gemcitabine + lobaplatin versus gemcitabine + cisplatin as second-line treatment in metastatic breast cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Lobaplatin (Primary) ; Cisplatin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Dec 2011 New trial record